Available Sizes:

VascularEmergency
1.4 in x 1.4 in (3.5 x 3.5 cm)3 in x 2 in (8 x 5 cm)
2 in x 2 in (5 x 5 cm)3 in x 3 in (8 x 8 cm)

(NSN Code: 6510-72-057-0464)

Hemostatic Dressing

USFDA Cleared, 510(k) K202830
NSN codified

The Axiostat Patch is a sterile, single use, non-absorbable hemostatic dressing composed of Chitosan, a well-known natural polysaccharide which has widely recognized hemostatic properties. Axiostat’s structure allows it to rapidly absorb and lock blood plasma during its hemostasis action. Axiostat is available in 40+ countries across the globe.

The Axiostat Patch is a sterile, single use, non-absorbable hemostatic dressing composed of Chitosan, a well-known natural polysaccharide generally derived from shellfish which has widely recognized hemostatic properties. Axiostat’s highly porous matrix with honeycomb microstructure with uniform porosity allows it to rapidly absorb and lock blood plasma during its hemostasis action. Axiostat is available in 50+ countries across the globe.

Quick Hemostasis

Plasma sorption, rapid platelet aggregation, activation of related pathways leading to significantly fast clot formation

Adaptive to multiple sheath sizes

Axiostat stops bleeding during withdrawal of sheath of all sizes

Acts as a Barrier to Bacteria

Axiostat provides a barrier to bacterial penetration thereby reducing the chance of infection

Clinical Use

Axiostat Patch is intended for local management of moderate to severe bleeding wounds and provides a barrier to bacterial penetration. Axiostat’s structure allows it to rapidly absorb and lock blood plasma during its hemostasis action. The dressing is indicated for the following wounds:

How to use Axiostat

  1. Open the pack and remove Axiostat Patch.
  2. Can be cut or folded as per the wound size
  3. Place Axiostat Patch such that it covers the entire bleeding site. Apply uniform pressure until hemostasis is achieved.
  4. Do not move Axiostat Patch after applying.
  5. Use another Axiostat Patch in case bleeding is not controlled or dressing is completely saturated with blood.
  6. Apply a secondary dressing to ensure Axiostat Patch remains in position.
  7. Remove the Patch within 24 hours by irrigating with plenty of water or saline.
  1. Open the pack and remove Axiostat Patch.
  2. Can be cut or folded as per the wound size
  3. Place Axiostat Patch such that it covers the entire bleeding site. Apply uniform pressure until hemostasis is achieved.
  4. Do not move Axiostat Patch after applying.
  5. Use another Axiostat Patch in case bleeding is not controlled or dressing is completely saturated with blood.
  6. Apply a secondary dressing to ensure Axiostat Patch remains in position.

Remove the Patch within 24 hours by irrigating with plenty of water or saline.

Ordering Information – Vascular

Product Description Product Code Product Size Packaging
Axiostat® Patch V55 V55 5 x 5 cm (2 x 2 in) 10 Units
Axiostat® Patch V35 V35 3.5 x 3.5 cm (1.4 x 1.4 in) 10 Units

Ordering Information – Emergency

Product Description NSN Code Product Code Product Size Packaging
Axiostat® Patch L88 6510-72-057-0464 L88 8 x 8 cm (3.15 x 3.15 in) 10 Units
Axiostat® Patch M85 M85 8 x 5 cm (3.15 x 2 in) 10 Units

Interested to Know More about Axiostat Patch?

The Axiostat Patch is a sterile, single use, non-absorbable hemostatic dressing composed of Chitosan, a well-known natural polysaccharide which has widely recognized hemostatic properties. Axiostat’s highly porous matrix with honeycomb microstructure with uniform porosity allows it to rapidly absorb and lock blood plasma during its hemostasis action. Axiostat is available in 50+ countries across the globe.

Composition:

Axiostat Patch is made up of chitosan extracted from shellfish. Natural material tends to change color. Hemostatic effectiveness remains un-changed.

Actions:

When applied with pressure, Axiostat Patch creates a mechanical barrier against bleeding.

Indications:

Axiostat Patch is intended for local management of moderate to severe bleeding wounds and provides a barrier to bacterial penetration. The dressing is indicated for the following wounds: lacerations, abrasions, surgical debride-ment sites, skin surface puncture sites, vascular procedure sites and sites involving percutaneous catheters, tubes and pins.

Warnings:

  • Remove within 24 hours.
  • It is a non-absorbable hemostatic dressing. Do not implant.
  • Do not use if patient is allergic to shellfish.
  • Do not use if package is damaged or contents are wet.
  • For single use only. Do not re-use or re-sterilize
  • Axiostat Patch when used in vascular procedures, must be under the supervision of a trained healthcare professional. Observe sterile techniques at all times when using Axiostat Patch in vascular application. Recommend sterile gauze usage to apply uniform pressure and to hold Axiostat Patch in position during vascular procedures.
  • After bleeding is controlled, do not remove Axiostat Patch immediately. Keep in position for at least 10 minutes.
  • Axiostat Patch is intended for temporary control of bleeding only.

Precautions:

Employ appropriate groin management post procedure and post hospital discharge to prevent infection when Axiostat Patch is used during vascular procedures.

Notify physician if any of the following occur:

  • Bleeding or significant drainage from the puncture site.
  • Swelling, redness or warmth around the puncture site.
  • Increased tenderness, numbness or cold sensation around the puncture site.

The safety and effectiveness of the Axiostat Patch has not been evaluated in the following patient populations:

  • Patients with uncontrolled hypertension (>180 mm Hg systolic).
  • Patients with bleeding disorders such as Thrombocytopenia (<100,000 platelet count), thrombasthenia, von Wille Brand’s disease, or anaemia (Hgb<10 mg/dl, Het<30).
  • Patients receiving glycoprotein IIb/Illa inhibitors before, during, or after the catheterization procedure.
  • Patients with bleeding diathesis or coagulopathy.
  • Patients already having hematoma/pseudoaneurysm.
  • Patients having ACT (Activated Clotting Time) > 180 sec.
  • Patients undergoing therapeutic thrombolysis.
  • Patients with auto-immune disorder and on medications for treating the same.

Refer the below tables for the duration of use of Axiostat Patch during vascular puncture procedures:

For Radial Access

Sheath Size Heparin Dosage Duration of manual compression with Axiostat Dressing Time To remove secondary dressing
6-8Fr Diagnostic Procedure 5000 to 7000 units/mL Approx. 3 minutes Not before 45 minutes
6-8Fr PCI(Percutaneous Coronary Intervention) 7500 to 9000 units/mL Approx. 5 minutes Not before 90 minutes
6-8Fr PCI(Percutaneous Coronary Intervention) or above Above 9000 units/mL Approx. 8 minutes Not before 180 minutes

For Femoral Access

Sheath Size Heparin Dosage Duration of manual compression with Axiostat Dressing Time To remove secondary dressing
6-8Fr Diagnostic Procedure 5000 to 7000 units/mL Approx. 5 minutes Not before 360 minutes
9-12Fr Diagnostic Procedure 7500 to 12000 units/mL Approx. 8 minutes Not before 360 minutes
6-12Fr PCI(Percutaneous Coronary Intervention) or above 6000 to 12000 units/mL Approx. 10 minutes Not before 360 minutes

Pivotal study on Hemostats & their mechanism of action in controlling massive bleeding: A collaborative study with Harvard Medical School

Architecturally Engineered Chitosan Hemostat for Rapid Bleeding Control on Anticoagulant Therapy

Summary: Architecturally Engineered Chitosan Hemostat for Rapid Bleeding Control on Anticoagulant Therapy

Axiostat Publications

Efficacy and Safety of Axiostat
Evaluation of Hemostatic Effectiveness in a Standard Swine Hemorrhage

Feel free to Contact us

To know more contact
office@advamedica.com

© Advamedica Inc. 2024, All Rights Reserved.